Literature DB >> 16491600

Markers of apoptosis.

Fazlul H Sarkar1, Yiwei Li.   

Abstract

Apoptosis is a physiological process that occurs in cells during development and normal cellular processes. The useless, unwanted, or damaged cells die during the apoptotic process. However, if signals instructing cells to carry out apoptosis are lost, a variety of malignant disorders may result. Normal mammary gland development is controlled by a balance between cell proliferation and apoptosis, and the balance is important for normal mammary gland differentiation. The formation of breast cancer will happen as soon as the balance is upset by carcinogens. The uncontrolled cell proliferation and the reduced levels of apoptosis will result in cancer growth. It is useful to detect apoptosis in breast cancer to determine the malignancy of the cancer. It is also important to measure the apoptosis index in breast cancer or other cancers treated with anticancer agents to verify the effect of the anticancer agent. In this chapter, we provide detailed protocols of commonly used apoptosis assays, including DNA ladder formation, enzyme-linked immunosorbent assay for histone/DNA fragment, poly-ADP-ribose-polymerase cleavage assay, and terminal deoxynucleotidyl transferase-mediated dUTP nick-end-labeling assay.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16491600     DOI: 10.1385/1-59259-969-9:147

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


  2 in total

1.  Enhanced anti-fibrogenic effects of novel oridonin derivative CYD0692 in hepatic stellate cells.

Authors:  Fredrick J Bohanon; Xiaofu Wang; Brittany M Graham; Anesh Prasai; Sadhashiva J Vasudevan; Chunyong Ding; Ye Ding; Geetha L Radhakrishnan; Cristiana Rastellini; Jia Zhou; Ravi S Radhakrishnan
Journal:  Mol Cell Biochem       Date:  2015-09-07       Impact factor: 3.396

2.  Oxidative stress mediated by gyrophoric acid from the lichen Umbilicaria hirsuta affected apoptosis and stress/survival pathways in HeLa cells.

Authors:  Michal Goga; Martin Kello; Maria Vilkova; Klaudia Petrova; Martin Backor; Wolfram Adlassnig; Ingeborg Lang
Journal:  BMC Complement Altern Med       Date:  2019-08-19       Impact factor: 3.659

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.